Sectors
ORKA
Oruka Therapeutics, Inc.
104.67
1 x 102.20
1 x 106.73
bid
ask
-
0.47
0.44%
1 @ 04:00 PM
103.00 -1.67 (1.60%)
| Ytd | 245.35% | |
| 1y | 702.11% |
102.31
day range
107.55
13.06
52 week range
107.55
| Open | 107.55 | Prev Close | 105.14 | Low | 102.31 | High | 107.55 | Mkt Cap | 6.31B |
| Vol | 688.57K | Avg Vol | 1.30M | EPS | -1.94 | P/E | -53.96 | Forward P/E | -39.65 |
| Beta | -0.34 | Short Ratio | 4.99 | Inst. Own | 103.61% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 82.71 | 200-d Avg | 51.16 | 1yr Est | 148.17 |
| Income Statement | |||
| Operating Expenses | 36.43M | ||
| Research and Development Expense | 29.15M | ||
| Selling, General and Administrative Expense | 7.29M | ||
| Operating Income | -36.43M | ||
| Net Income | -31.82M | ||
| Net Income Common Stock | -31.82M | ||
| Net Income Common Stock (USD) | -31.82M | ||
| Consolidated Income | -31.82M | ||
| Earnings per Basic Share | -0.48 | ||
| Earnings per Basic Share (USD) | -0.48 | ||
| Earnings per Diluted Share | -0.48 | ||
| Earning Before Interest & Taxes (EBIT) | -31.82M | ||
| Earning Before Interest & Taxes (USD) | -31.82M | ||
| Weighted Average Shares | 55.17M | ||
| Weighted Average Shares Diluted | 55.17M | ||
| Balance Sheet | |||
| Cash and Equivalents | 49.52M | ||
| Cash and Equivalents (USD) | 49.52M | ||
| Investments | 446.43M | ||
| Investments Current | 339.31M | ||
| Investments Non-Current | 107.12M | ||
| Current Assets | 395.25M | ||
| Property, Plant & Equipment Net | 2.01M | ||
| Total Assets | 504.48M | ||
| Debt Current | 680.00K | ||
| Total Debt | 1.81M | ||
| Current Liabilities | 16.63M | ||
| Debt Non-Current | 1.13M | ||
| Total Liabilities | 17.76M | ||
| Accumulated Retained Earnings (Deficit) | -220.98M | ||
| Accumulated Other Comprehensive Income | -480.00K | ||
| Shareholders Equity | 486.72M | ||
| Shareholders Equity (USD) | 486.72M | ||
| Assets Non-Current | 109.23M | ||
| Total Debt (USD) | 1.81M | ||
| Liabilities Non-Current | 1.13M | ||
| Trade and Non-Trade Payables | 3.66M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 186.00K | ||
| Net Cash Flow from Financing | 40.60M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.59M | ||
| Capital Expenditure | -73.00K | ||
| Issuance (Purchase) of Equity Shares | 40.60M | ||
| Net Cash Flow from Investing | -14.44M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -14.36M | ||
| Net Cash Flow from Operations | -23.58M | ||
| Share Based Compensation | 6.97M | ||